Neurotrophic factors in diabetic neuropathy

Current Opinion in Endocrinology and Diabetes

Volumn 8, Issue 4, 2001, Pages 205-212

  Vinik, A I ^a   Pittenger, G ^a   Park, T S ^a   Erbas, T ^a   Skeen, M ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 PHOSPHONOMETHYLPIPECOLIC ACID; BASIC FIBROBLAST GROWTH FACTOR; CYCLOSPORIN A; CYTOKINE; DIZOCILPINE; FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 12; FK 506 BINDING PROTEIN 52; GLUTAMIC ACID; GPI 5232; GPI 5241; GPI 5421; IMMUNOPHILIN; INTERLEUKIN 6; INTERLEUKIN DERIVATIVE; LAMININ; N ACETYLASPARTYLGLUTAMIC ACID; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; PROSAPOSIN; PROSAPTIDE TX14; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN C; TACROLIMUS; TOPIRAMATE; UNCLASSIFIED DRUG;

APOPTOSIS; CELL DIFFERENTIATION; CELL GROWTH; CLINICAL TRIAL; DIABETIC NEUROPATHY; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; DRUG SCREENING; GENE THERAPY; HUMAN; MULTIGENE FAMILY; NERVE CELL PLASTICITY; NERVE GROWTH; NERVE INJURY; NERVE REGENERATION; NEUROTOXICITY; NONHUMAN; PROTEIN FAMILY; REVIEW;

EID: 0034909499     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-200108000-00007     Document Type: Review

References (78)

1. Diagnosis and management of diabetic neuropathy
2. Disordered nerve survival and regeneration in diabetes
3. Nitric oxide mediates the change of proteoglycan synthesis in the human lumbar intervertebral disc in response to hydrostatic pressure
4. The nerve growth factor: Thirty-five years later
5. Attenuation and recovery of nerve growth factor receptor mRNA in dorsal root ganglion neurons following axotomy
6. Nerve growth factor protects adult sensory neurons from cell death and atrophy caused by nerve injury
7. Effects of nerve growth factor on cholinergic brain neurons
8. Treatment of diabetic polyneuropathy (DPN) with recombinant human nerve growth factor (rhNGF)
9. Increased levels of nerve growth factor in the urinary bladder and hypertrophy of dorsal root ganglion neurons in the diabetic rat
10. Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy
11. Death of some dorsal root ganglion neurons and plasticity of others following sciatic nerve section in adult and neonatal rats
12. Streptozotocin-induced diabetes decreases substance P levels in experimental arthritis in the rat knee
13. Axonal transport and tissue contents of substance P in rats with long-term streptozotocin-diabetes. Effects of the aldose reductase inhibitor 'statil'
14. Nerve growth factor treatment ameliorates diabetic sensory neuropathy
15. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy
16. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy
17. Sensory nerves in skin
18. Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies
19. Painful sensory neuropathy: Prospective evaluation using skin biopsy
20. Painful sensory neuropathy: Prospective evaluation of painful feet using electrodiagnosis and skin biopsy
21. Primary nociceptive afferents mediate the blood flow dysfunction in non-glabrous (hairy) skin of type 2 diabetes
22. Independent effects of peripheral nerve dysfunction on lower-extremity physical function in old age
23. Merosin, a tissue-specific basement membrane protein, is a laminin-like protein
24. Nerve regeneration and Schwann cell basal lamina: Observations of the long-term regeneration
25. Schwann cell basal lamina and nerve regeneration
26. Neurite-promoting factors and extracellular matrix components accumulating in vivo within nerve regeneration chambers
27. Laminin promotes neuritic regeneration from cultured peripheral and central neurons
28. Rapid effects of laminin on the growth cone
29. Nonenzymatic glycosylation of laminin and the laminin peptide CIKVAVS inhibits neurite outgrowth
30. A biologic role for carbohydrate moieties of laminin
31. Laminin alterations after in vitro non-enzymatic glycosylation
32. Up-regulation of laminin B2 gene expression in dorsal root ganglion neurons and non-neuronal cells during sciatic nerve regeneration
33. Laminin B2 mRNA is upregulated in sensory neurons and Schwann cells during peripheral nerve regeneration
34. Laminin gene expression in diabetic rat dorsal root ganglia
35. Differential expression of laminin genes in dorsal root ganglia during sciatic nerve regeneration
36. Cytotoxicity of serum on sensory/autonomic and motor neural cells in vitro predicts sensory neuropathy
37. Serum from patients with diabetic neuropathy impairs laminin neuroprotection by altering laminin receptor integrin expression
38. Identification of prosaposin as a neurotrophic factor
39. Identification of the neurotrophic factor sequence of prosaposin
40. Prosaposin gene expression and the efficacy of a prosaposin-derived peptide in preventing structural and functional disorders of peripheral nerve in diabetic rats
41. Prosaptide prevents paclitaxel neurotoxicity
42. Cell death prevention, mitogen-activated protein kinase stimulation, and increased sulfatide concentrations in Schwann cells and oligodendrocytes by prosaposin and prosaptides
43. Prosaptide prevents hyperalgesia and reduces peripheral TNFR1 expression following TNF-a nerve injection
44. Lysosomal proteolysis of prosaposin, the precusor of saposins (Sphingolipid Activator Proteins): Its mechanism and inhibition by ganglioside
45. Phosphatidylinositol 3-kinase and akt protein kinase mediate IGF-I- and prosapitde-induced survival in schwann cells
46. Prosaposin prevents programed cell death of rat cerebellar granule neurons in culture
47. Prosaptide activates the MAPK pathway by a G-protein-dependent mechanism essential for enhanced sulfatide synthesis by Schwann cells
48. Reversal of the thermal hyperalgesia in a rat partial sciatic nerve ligation model by prosaptide TX14(A)
49. Postnatal expression of interleukin-6 (IL-6) receptor (IL-6R) mRNAs in rat sympathetic and sensory ganglia
50. Accelerated nerve regeneration in mice by upregulated expression of interleukin (IL)6 and IL-6 receptor after trauma
51. Cytokines and peripheral nerve disorders
52. Interleukin-1 receptors: Cloning studies and role in central nervous system disorders
53. Voltage-dependent modulation of N-type calcium channels by G-protein βγ subunits
54. Tumor necrosis factor alpha and interleukin-6 mRNA expression in neonatal Lewis rat Schwann cells and a neonatal rat Schwann cell line following interferon gamma stimulation
55. Sympathetic neurons can produce and respond to interleukin 6
56. Neurotrophic role of interleukin-6 and soluble interleukin-6 receptors in NIE-115 neuroblastoma cells
57. Interleukin-6 (IL-6) and its soluble receptor support survival of sensory neurons
58. Neuroimmunophilin ligands: Evaluation of their therapeutic potential for the treatment of neurologic disorders
59. Steady-state polypeptide modulations associated with nerve growth factor (NGF)-induced terminal differentiation and NGF deprivation-induced apoptosis in human neuroblastoma cells
60. Serum from patients with type 2 diabetes with neuropathy induces complement-independent, calcium-dependent apoptosis in cultured neuronal cells
61. The neuronal toxic factor in serum of type 1 diabetic patients is a complement-fixing autoantibody
62. The nagging question of the function of N-acetylaspartylglutamate
63. NAAG selectively activates mGluR3 receptors in transfected cells
64. N-acetyl-aspartylglutamate modulation of N-methyl-D-aspartate-stimulated [3H]norepinephrine release from rat hippocampal slices
65. The regional distribution of N-acetylaspartylglutamate (NAAG) and peptidase activity against NAAG in the rat nervous system
66. On line continuous monitoring of subcutaneous tissue glucose in men by combining portable glucosensor with microdialysis
67. H1 cells
68. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death
69. Protection against ischemic neuronal damage by drugs acting on excitatory neurotransmission
70. A review of earlier clinical studies on neuroprotective agents and current approaches
71. Activation of class II or III metabortrophic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration
72. N-aceylated alpha-linked acidic dipeptidase may be involved in axon-Schwann cell signalling
73. NMDA-receptor activation occurs during recovery in a tissue culture model of ischemia
74. Topiramate: Pharmacokinetics and pharmacodynamics
75. Efficacy and safety of topiramate in the treatment of painful diabetic neuropathy: A double-blind, placebo-controlled study
76. Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolization
77. Protective effect of topiramate against hippocampal neuronal damage after global ischemia in the gerbils
78. Effect of topiramate on body weight and body composition of osborne-mendel rats fed a high-fat diet: Alterations in hormones, neuropeptide, and uncoupling-protein mRNAs